News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Michael C. Kaufmann to Become Chief Financial Officer of Cardinal Health; Jon Giacomin to Lead Pharmaceutical Segment
09/11/2014

DUBLIN, Ohio, Sept. 11, 2014 /PRNewswire/ -- Cardinal Health announced today that Michael C. Kaufmann, 51, has been named chief financial officer of the company effective Nov. 11, 2014. This follows the previously announced planned retirement of current Chief Financial Officer Jeffrey W. Henderson, 49.  Jon Giacomin, 49, has been named to the role of chief executive officer of the Pharmaceutical segment, currently held by Mike Kaufmann, also effective Nov. 11, 2014.

MICHAEL C. KAUFMANN TO BECOME CHIEF FINANCIAL OFFICER OF CARDINAL HEALTH

"Over the past 24 years, Mike has demonstrated a track record of high performance across many roles for Cardinal Health.  His unique blend of financial acumen and extensive operational experience make him ideally suited to take the position of CFO," said George Barrett, chairman and chief executive officer of Cardinal Health.  "We are excited to work with Mike in this new capacity.  I'm thrilled that this move also allows us to bring Jon Giacomin into the Pharmaceutical segment leadership role.  We are privileged to have the opportunity to draw from the deep well of our internal talent."

Kaufmann has served in the role of chief executive officer of Cardinal Health's Pharmaceutical segment since 2009.  He joined Cardinal Health in 1990 and held a number of senior operational, sales and finance positions. These positions included group president of the medical business of the former Healthcare Supply Chain segment, after serving as the segment's CFO.  Prior to joining Cardinal Health, Kaufmann had a successful career in audit and consulting with Arthur Andersen, formerly one of the nation's largest public accounting firms.

Kaufmann is a member of the executive committee of the boards of the Healthcare Distribution Management Association and the National Association of Chain Drug Stores, and a trustee at Ohio Northern University. Kaufmann is the executive sponsor of the Cardinal Health Women's Initiative Network Employee Resource Group, which is dedicated to fostering partnerships that create a great place for women to work and grow their careers, while building a sustainable competitive advantage for Cardinal Health.

He earned a bachelor's degree in business administration from Ohio Northern University.

To ensure a seamless transition, current Cardinal Health CFO Jeff Henderson will remain as an employee until his retirement just past the end of the fiscal year in August 2015.  He will continue to have oversight for Cardinal Health China, in addition to working with the Cardinal Health leadership team on significant initiatives.

Jon Giacomin to lead Pharmaceutical segment

A 12-year veteran of Cardinal Health, Giacomin currently serves as president of U.S. Pharmaceutical Distribution. Prior to this, he was executive vice president of Pharmaceutical Operations, where he was responsible for warehouse operations at 22 distribution centers and pharmaceutical packaging operations. Giacomin joined Cardinal Health in the Pharmaceutical packaging business and served as its vice president and general manager before moving to the position of senior vice president of inventory management for the former Healthcare Supply Chain Services segment.

Prior to joining Cardinal Health, Giacomin held engineering and operating roles for Griffith Micro Science and Sterigenics.  He also served as a lieutenant in the U.S. nuclear Navy, where he held an engineering role.

He currently serves on the boards of trustees of the National Association of Chain Drug Stores Foundation and the Cardinal Health Foundation and as the executive sponsor of the Cardinal Health Veterans and Military Advocates Employee Resource Group.

He earned a bachelor's degree in mechanical engineering from the University of Notre Dame and an MBA from the University of Chicago.

About Cardinal Health, Inc.  
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $91 billion health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers, clinical laboratories and physician offices focus on patient care while reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products and services to more than 100,000 locations each day and is also the industry-leading direct-to-home medical supplies distributor. The company is a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company operates the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #22 on the Fortune 500, Cardinal Health employs 34,000 people worldwide. More information about the company may be found at www.cardinalhealth.com and @CardinalHealth on Twitter.

JON GIACOMIN TO LEAD PHARMACEUTICAL SEGMENT OF CARDINAL HEALTH

Photo - http://photos.prnewswire.com/prnh/20140910/145326
Photo - http://photos.prnewswire.com/prnh/20140910/145417

SOURCE Cardinal Health

For further information: Media: Debbie Mitchell, (614) 757-6225, debbie.mitchell@cardinalhealth.com, or Investors: Sally Curley, (614) 757-7115, sally.curley@cardinalhealth.com
More Company News
04/02/2024

The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products COLUMBUS, Ohio, April 2, 2024 /PRNewswire/ --...

03/26/2024

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New York Stock Exchange. The company will...

03/15/2024

Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions...

02/29/2024

Study reveals impact of dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability DUBLIN, Ohio, Feb. 29, 2024...

View all company news »